Millendo Therapeutics, Inc. Recorded Big Gain

Millendo Therapeutics, Inc. (MLND:NASDAQ) rocketted at $1.17, a gain of 18.9%. The stock appeared on our News Catalysts scanner on Sun, Apr 18, 2021 at 07:23 AM in the 'INVESTOR UPDATE' category. From Tue, Apr 13, 2021, the stock recorded 30.00% Up Days and 27.27% Green Days

The stock spiked on Wed, Feb 10, 2021 at $2.77 with a volume of 1M+, and its share price has been moving sideways in recent weeks.

About Millendo Therapeutics, Inc. (MLND:NASDAQ)

OvaScience Inc is a biotechnology company focused on discovering, developing, and commercializing new fertility treatment options for women. The company's patented technology is based on a new fertility treatment option, "the newly discovered Egg precursor cells." Augment, the first treatment, is designed to improve egg health: Energy-producing mitochondria from a patient's own EggPC cells are added to the patient's mature eggs. The OvaPrime treatment is a fertility treatment that could allow a woman to increase her own egg reserve. The OvaTure treatment is a potential next-generation fertility treatment that could allow a woman produce healthy, young, fertilizable eggs without hormone injections.